Cancer

New Therapies for Brain Cancer

Glioblastoma: New Therapies for Brain Cancer

Launched

2019 June

<p><strong></strong>Glioblastoma is a deadly disease, but researchers at the MUHC have uncovered a therapy that may change the prognosis for patients.<em></em></p>

Glioblastoma is a deadly disease, but researchers at the MUHC have uncovered a therapy that may change the prognosis for patients.

It’s a diagnosis that can devastate a patient – glioblastoma multiforme. It is an extremely aggressive brain tumor that is resistant to treatment. Radiotherapy, chemotherapy, even extensive attempts to remove the tumor surgically cannot force the cancer into remission, leaving physicians with few options. Despite the emergence of intensive treatment strategies, the median survival of patients with glioblastoma is 16 months and only 3-5% of patients survive longer than 3 years.

Progress

Money raised to date

$ 0

$ 102,669
$ 700,000
15%

01

What

Glioblastoma and the MUHC

In response to the devastation of glioblastoma, Dr. Bassam Abdulkarim of the Research Institute of the McGill University Health Centre (RI-MUHC) is working with a diverse team of physicians and researchers to discover new therapies for patients diagnosed with glioblastoma. After years of research and development, the MUHC’s Cancer Therapeutics Research Team is proud to have discovered a promising new therapy, called ZR2002. The drug will soon be ready for clinical trials, the first step toward making it available to patients.

Help Us End Cancer

Read Our Inspiring Stories 

Read Here